GSK-PLK107427



A Phase I Study to Determine the Safety, Pharmacokinetics, and Pharmacodynamics of [GSK461364], a Polo-like Kinase 1 (PLK1) Inhibitor, in Adult Subjects with Advanced Solid Tumor or Non-Hodgkins Lymphoma
GSK461364
PLK107427
NCT00536835
Lymphoma, Non-Hodgkin
Phase 1
 
August 2015